Industries > Pharma > Global Infusion Devices Market Forecast to 2027

Global Infusion Devices Market Forecast to 2027

Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, other Infusion Pumps

PUBLISHED: 15 December 2017
PAGES: 231
PRODUCT CODE: PHA0268

Clear
WOOCS 2.2.1

The global infusion devices market is expected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the insulin pumps submarket held the 31% of the global infusion devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 83 tables and 65 figures – all unavailable elsewhere.

The 231-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Medical Infusion Devices market forecasts to 2027

• This report also breaks down the revenue forecast for global infusion devices market by these submarkets:
– Insulin pumps,
– Enteral feeding pumps
– Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)

Global Infusion Devices Market Forecast to 2027

This report analyses and dicusses the drivers and restraints for each submarket.

• Our work also shows individual revenue forecasts to 2027 for 12 national markets:
– United States (US)
– Japan
– EU leaders
– Germany, France, the UK, Italy and Spain (EU5)
– BRIC nations – Brazil, Russia, India and China.
– South Korea
– RoW

• Our work also shows individual revenue forecasts to 2027 for the Global Drug Delivery Technology market, broken down by these submarkets:
– Oral drug delivery
– Inhalation drug delivery
– Injectable/implantable drug delivery
– Transdermal drug delivery
– Ocular drug delivery
– Nasal drug delivery

• This report discusses the leading products in the global infusion devices market, from several leading companies, including:
– ALCOR Scientific
– Altea Therapeutics
– Animas Corporation
– B.Braun
– Baxter
– CareFusion
– Cellnovo
– Covidien
– D. Medical Industries
– Danone Nutricia
– Debiotech
– Disetronic (Roche)
– Fresenius Kabi
– Hospira
– Insulet Corporation
– Johnson & Johnson
– Medline
– MedSolve Technologies
– Medtronic
– Q Core Medical
– Roche
– Smiths Medical
– SOOIL
– Tandem Diabetes Care
– Valeritas
– Zevex

• This report provides a SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced. Moreover, this report proves Porter’s Five Forces Analysis of the global infusion devices market.

Visiongain’s study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Infusion Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Infusion Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories